Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Return on Equity (2020 - 2025)

BioAtla (BCAB) has 6 years of Return on Equity data on record, last reported at 2.71% in Q3 2025.

  • For Q3 2025, Return on Equity rose 572.0% year-over-year to 2.71%; the TTM value through Sep 2025 reached 2.71%, up 572.0%, while the annual FY2024 figure was 1.66%, 68.0% down from the prior year.
  • Return on Equity reached 2.71% in Q3 2025 per BCAB's latest filing, down from 7.64% in the prior quarter.
  • Across five years, Return on Equity topped out at 7.64% in Q2 2025 and bottomed at 8.72% in Q1 2025.
  • Average Return on Equity over 5 years is 0.93%, with a median of 0.66% recorded in 2022.
  • The widest YoY moves for Return on Equity: up 1022bps in 2025, down -674bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.44% in 2021, then tumbled by -51bps to 0.66% in 2022, then crashed by -126bps to 1.49% in 2023, then plummeted by -154bps to 3.79% in 2024, then soared by 171bps to 2.71% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 2.71% in Q3 2025, 7.64% in Q2 2025, and 8.72% in Q1 2025.